SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010395
Filing Date
2021-08-05
Accepted
2021-08-05 07:42:25
Documents
102
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210630x10q.htm   iXBRL 10-Q 2264568
2 EX-3.8 tmb-20210630xex3d8.htm EX-3.8 14847
3 EX-10.1 tmb-20210630xex10d1.htm EX-10.1 120575
4 EX-31.1 tmb-20210630xex31d1.htm EX-31.1 10560
5 EX-31.2 tmb-20210630xex31d2.htm EX-31.2 10614
6 EX-32.1 tmb-20210630xex32d1.htm EX-32.1 7913
7 GRAPHIC tmb-20210630xex10d1002.jpg GRAPHIC 7354
  Complete submission text file 0001558370-21-010395.txt   9995088

Data Files

Seq Description Document Type Size
8 EX-101.SCH tmb-20210630.xsd EX-101.SCH 89303
9 EX-101.CAL tmb-20210630_cal.xml EX-101.CAL 56375
10 EX-101.DEF tmb-20210630_def.xml EX-101.DEF 423768
11 EX-101.LAB tmb-20210630_lab.xml EX-101.LAB 568967
12 EX-101.PRE tmb-20210630_pre.xml EX-101.PRE 630263
13 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210630x10q_htm.xml XML 1564260
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 211146359
SIC: 2834 Pharmaceutical Preparations